Ionis Pharmaceuticals IONS reported its Q1 earnings results on Wednesday, May 3, 2023 at 07:00 AM.
Here's what investors need to know about the announcement.
Earnings
Ionis Pharmaceuticals beat estimated earnings by 25.27%, reporting an EPS of $-0.68 versus an estimate of $-0.91.
Revenue was down $11.00 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.26 which was followed by a 0.3% drop in the share price the next day.
Here's a look at Ionis Pharmaceuticals's past performance:
Quarter | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
---|---|---|---|---|
EPS Estimate | -0.92 | -0.74 | -0.62 | -0.71 |
EPS Actual | -1.18 | -0.16 | -0.56 | -0.27 |
Revenue Estimate | 158.65M | 143.84M | 140.70M | 125.21M |
Revenue Actual | 152.00M | 160.00M | 134.00M | 142.00M |
To track all earnings releases for Ionis Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.